[1]
|
E. H. Derrick, “‘Q’ Fever, a New Fever Entity: Clinical Features, Diagnosis and Laboratory Investigation,” Medical Journal of Australia, Vol. 2, 1937, pp. 281-229.
|
[2]
|
D. Raoult, et al., “Q Fever 1985-1998. Clinical and Epidemiologic Features of 1383 Infections,” Medicine (Baltimore), Vol. 79, No. 2, 2000, pp. 109-123.
doi:10.1097/00005792-200003000-00005
|
[3]
|
D. Raoult and T. Marrie, “Q Fever,” Clinical Infectious Diseases, Vol. 20, No. 3, 1995, p. 489.
doi:10.1093/clinids/20.3.489
|
[4]
|
F. Fenollar, P. E. Fournier, M. P. Carrieri, G. Habib, T. Messana and D. Raoult, “Risks Factors and Prevention of Q Fever Endocarditis,” Clinical Infectious Diseases, Vol. 33, No. 3, 2001, pp. 312-316. doi:10.1086/321889
|
[5]
|
D. Raoult and F. Fenollar, “Stein A. Q Fever during Pregnancy: Diagnosis, Treatment, and Follow-Up,” Archives of Internal Medicine, Vol. 162, No. 6, 2002, pp. 701-704.
doi:10.1001/archinte.162.6.701
|
[6]
|
H. Tissot-Dupont, V. Vaillant, S. Rey and D. Raoult, “Role of Sex, Age, Previous Valve Lesion, and Pregnancy in the Clinical Expression and Outcome of Q Fever after a Large Outbreak,” Clinical Infectious Diseases, Vol. 44, No. 2, 2007, pp. 232-237. doi:10.1086/510389
|
[7]
|
X. Carcopino, D. Raoult, F. Bretelle, L. Boubli and A. Stein, “Managing Q Fever during Pregnancy: The Benefits of Long-Term Cotrimoxazole Therapy,” Clinical Infectious Diseases, Vol. 45, No. 5, 2007, pp. 548-555.
doi:10.1086/520661
|
[8]
|
A. Kumar, M. P. Yadav and S. Kakkar, “Human Milk as a Source of Q-Fever Infection in Breast-Fed Babies,” Indian Journal of Medical Research, Vol. 73, 1981, pp. 510-512.
|
[9]
|
B. N. Prasad, N. K. Chandiramani and A. Wagle, “Isolation of Coxiellaburnetii from Human Sources,” International Journal of Zoonoses, Vol. 13, No. 2, 1986, pp. 112-117.
|
[10]
|
A. Stein and D. Raoult, “Q Fever during Pregnancy: A Public Health Problem in Southern France,” Clinical Infectious Diseases, Vol. 27, No. 3, 1998, pp. 592-596.
doi:10.1086/514698
|
[11]
|
D. Raoult and D. Stein, “Q Fever during Pregnancy: A Risk for Women, Fetuses, and Obstetricians [Letter],” The New England Journal of Medicine, Vol. 330, No. 5, 1994, p. 371. doi:10.1056/NEJM199402033300518
|
[12]
|
J. Denman and M. Woods, “Acute Q Fever in Pregnancy: Report and Literature Review,” Internal Medicine Journal, Vol. 39, 2009, pp. 479-484.
doi:10.1111/j.1445-5994.2009.01933.x
|
[13]
|
W. A. Ray, et al., “Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes,” The New England Journal of Medicine, Vol. 351, No. 11, 2004, p. 1089.
doi:10.1056/NEJMoa040582
|
[14]
|
A. Boulos, et al., “Measurement of the Antibiotic Susceptibility of Coxiella burnetii Using Real Time PCR,” International Journal of Antimicrobial Agents, Vol. 23, No. 2, 2004, p. 169. doi:10.1016/j.ijantimicag.2003.07.007
|
[15]
|
A. Gikas, et al., “Newer Macrolides as Empiric Treatment for Acute Q Fever Infection,” Antimicrobial Agents and Chemotherapy, Vol. 45, No. 12, 2001, p. 3644.
doi:10.1128/AAC.45.12.3644-3646.2001
|